{"database": "lobbying", "table": "lobbying_activities", "rows": [[1700367, "f049a889-2022-43a6-9133-bfa1caf6b5b7", "Q2", "AMERICAN HEALTH CARE ASSOCIATION", 2491, "AMERICAN HEALTH CARE ASSOCIATION", 2015, "second_quarter", "PHA", "S. 621: Safe Prescribing Act of 2013 - continued monitoring of hydrocodone changes.\n\nContinued monitoring of Nurse Agent \n\nContinued monitoring of drug disposal issues\n\nContinued monitoring of action on antipsychotic reduction efforts.\n\nH.R. 3392 Medicare Part D patient Safety & Drug Abuse Prevention Act of 2013", "Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE,Veterans Affairs, Dept of (VA)", null, 960000, 0, 0, "2015-07-16T16:32:10.600000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1700367"], "units": {}, "query_ms": 16.400841006543487, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}